A20 is regulated by microRNA (miRNA) and acts as a regulator of endothelial cell ferroptosis [53], and the A20/TNFAIP3-CDC20-CASP1 axis promotes inflammation-mediated metastatic disease in triple-negative breast cancer [54]. This evidence concerns the gene CASP1 and triple-negative breast carcinoma.